Lidocain Egis

Lidocaine, the active ingredient in Lidocain Egis, is a local anesthetic presented as a topical formulation for skin application. It provides temporary numbing of the treated area and is used to relieve pain, itching and discomfort associated with minor skin procedures, superficial burns and insect bites.

GNH USA supplies Lidocain Egis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with manufacturing that meets EU market standards and rigorous quality controls.

Lidocain Egis, a topical lidocaine preparation, is employed in several dermatologic and minor procedural settings.

- Minor skin procedures: provides local anesthesia to reduce procedural pain. - Superficial burns: alleviates pain and discomfort from minor thermal injuries. - Dermatologic itching: reduces itch associated with insect bites, allergic reactions or mild irritations.

Lidocain Egis may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation: redness or mild burning at the application site. - Pruritus: localized itching after use. - Erythema: mild redness of the skin. - Swelling: slight edema around the treated area. - Allergic contact dermatitis: rash or hives localized to the site. - Tingling sensation: transient paresthesia.

Serious or Rare Side Effects: - Systemic toxicity: dizziness, seizures, or cardiac arrhythmia if absorbed in large amounts. - Anaphylaxis: severe allergic reaction with airway compromise. - Methemoglobinemia: reduced oxygen-carrying capacity of blood. - Tissue necrosis: severe local tissue damage. - Cardiovascular depression: hypotension or bradycardia. - Central nervous system depression: profound drowsiness or coma.

When using Lidocain Egis, consider the following precautions.

- Allergy assessment: avoid if known hypersensitivity to lidocaine or other amide anesthetics. - Application area: limit use to intact skin; do not apply to mucous membranes or open wounds. - Quantity control: use only the amount required for the target area to minimize systemic absorption. - Concurrent medications: exercise caution when other local anesthetics are used simultaneously. - Medical conditions: avoid in patients with severe heart block, liver impairment, or known cardiac conduction disorders. - Store at room temperature: keep in the original container, protect from moisture and light.

Lidocain Egis can interact with other drugs; monitor patients accordingly.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase systemic lidocaine levels. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise lidocaine concentration. - Other local anesthetics: additive toxicity risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance cardiac effects of lidocaine. - Loop diuretics (e.g., furosemide): may alter plasma protein binding. - General anesthetics: monitor for additive central nervous system depression.